One of the most common questions I hear in my office is some version of: "Do I actually qualify for a GLP-1?" It's a fair question, and the honest answer is that it depends on which question you're really asking. There are two very different gatekeepers here — the science, and your insurance company — and they often disagree. Let me walk you through both, plus the medications themselves and the areas where these drugs are being used beyond weight loss.

Last week, we covered the biology behind variable semaglutide response — why genetics, hormones, sleep, stress, and dosing all shape your results, and why a limited response is never simply a matter of trying harder.

This week: what to actually do about it. Here's the systematic, evidence-based approach we use at Healthy You when semaglutide isn't delivering the results a patient deserves.

You started semaglutide with real hope. You'd heard about the clinical trials, seen the results in the news, maybe watched a friend drop thirty pounds with ease. So when the scale barely moves — or stalls entirely after a modest start — the disappointment can feel personal. Like your body is broken. Like you're doing something wrong.

You're not.

Polycystic ovary syndrome affects approximately 1 in 10 women of reproductive age. It is the most common endocrine disorder in women. It drives infertility, metabolic disease, type 2 diabetes, cardiovascular risk, anxiety, depression, and a relentless daily burden of symptoms — irregular periods, hair loss, acne, weight gain that doesn't respond to effort, and a medical system that often dismisses all of it. And yet, there is not a single FDA-approved medication specifically indicated for PCOS.

Not one.